News & Events
Latest News
Catch up on the latest blogs, press releases, publications, and other news at Indica Labs.
HALO AP® is Now Rated in Best in KLAS®: Earning ‘A’ Grades in All Categories
Albuquerque, NM, February 12, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced recognition by KLAS for top customer-rated performance in the European digital pathology market.
Indica Labs Sets New Standard for Molecular Testing in Breast Cancer with Expansion of AI Macrodissection Portfolio
Albuquerque, NM, February 10, 2025 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced the expansion of its macrodissection portfolio with the launch of Breast Macrodissect AI . The suite now includes advanced algorithms for
Indica Labs Reports 260% Clinical Revenue Growth and Expansion into New Global Markets
Albuquerque, NM, December 17, 2025 – Indica Labs, the global leader in AI-powered digital pathology, announced today that clinical revenue growth rate for HALO AP® is up 260% since 2023 and recurring revenue for 2025 shows a 200% increase year-over-year,
Indica Labs Receives FDA Clearance for Enterprise Digital Pathology Platform with Industry Leading DICOM-Compatible Aperio Scanner from Leica Biosystems
ALBUQUERQUE, NM, and VISTA, CA, December 3, 2025 – Indica Labs, the global leader of AI-powered digital pathology, and Leica Biosystems, a global leader in anatomic and digital pathology solutions, announced today that the Food and Drug Administration (FDA) has
Fetal growth restriction (FGR) is a significant concern in obstetrics, affecting 5–10% of pregnancies globally. FGR is a major contributor to perinatal morbidity and mortality and poses a significant maternal risk due to potential co-occurrence with pre-eclampsia. Despite their impact,...
Learn More
Melanoma, a highly aggressive type of skin cancer originating from pigment-producing cells called melanocytes, can be a source of diagnostic confusion for pathologists. While primary melanomas are easily recognizable, metastatic melanomas can dedifferentiate and exhibit varied and misleading cyto-architectural characteristics,...
Learn More
High-grade serous ovarian cancer (HGSC) is known to have a high degree of both genetic and immunologic heterogeneity, can be resistant to chemotherapy, and commonly recurs in patients. It is also the most common form of ovarian cancer and represents...
Learn More
KLAS Recognition as a Catalyst for What Comes Next
We are proud to mark a significant milestone: HALO AP® earned the highest overall customer rating in the 2026 KLAS Global Software report for digital pathology. Because KLAS distinction is driven entirely by direct customer feedback, this recognition reflects the real-world performance, reliability, and impact of our platform in daily
Looking Back: Reviewing 2025 at Indica Labs
As we reach the end of 2025, the Indica Labs team extends our sincere thanks to the customers and collaborators who helped make this year one of remarkable innovation, growth, and scientific achievement.
Advancing Neuroscience Research with HALO® and HALO AI
As scientists work to continue unraveling the structural, cellular, and molecular complexities of the brain and its diseases, the characteristics of this unique tissue pose significant challenges to traditional histological analysis.
Announcing HALO® Muscle Fiber BF and Muscle Fiber FL Modules Supporting AI-Powered Segmentation and Interactive Markups
We’re excited to announce the launch of the newly updated Muscle Fiber BF and Muscle Fiber FL modules supporting AI nuclear segmentation, AI membrane segmentation, interactive markups, and new output metrics..
Unlocking the Potential of Antibody-Drug Conjugates (ADC) with HALO® Image Analysis and Indica Labs Pharma Services
Antibody-drug conjugates (ADC) represent one of the most promising classes of next-generation cancer therapeutics, combining antibody-based targeting with the potency of chemotherapy.
HALO®, HALO AI, and HALO Link 4.2 Features and Functionalities
In this blog post, you can learn about some of the new features in the 4.2 release, when to expect your chance to upgrade, and where to find user guides, release notes, and tutorial videos.
People of Pathology Podcast: Adam Smith – Making AI Accessible For All With Indica Labs
Adam Smith shares his journey from being a HALO® customer to helping lead Indica Labs’ mission of making AI accessible to pathologists everywhere.
12 Years of Digital Pathology Innovation and What to Expect Next
Kate Lillard Tunstall discusses Indica Lab’s 12-year journey in digital pathology, the impact of AI, and the future of the industry
HISTOHELP: ARTIFICIAL INTELLIGENCE – NOT SCARY AFTERALL!
Have you been listening to the National Society for Histotechnology HistoHelp podcast series? In their latest podcast, David Krull gives a great intro to AI for Digital Pathology. And even a shout out on the ease of use of HALO AI!
KLAS Recognition as a Catalyst for What Comes Next
We are proud to mark a significant milestone: HALO AP® earned the highest overall customer rating in the 2026 KLAS Global Software report for digital pathology. Because KLAS distinction is driven entirely by direct customer feedback, this recognition reflects the real-world performance, reliability, and impact of our platform in daily
HALO AP® is Now Rated in Best in KLAS®: Earning ‘A’ Grades in All Categories
Albuquerque, NM, February 12, 2026 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced recognition by KLAS for top customer-rated performance in the European digital pathology market.
Indica Labs Sets New Standard for Molecular Testing in Breast Cancer with Expansion of AI Macrodissection Portfolio
Albuquerque, NM, February 10, 2025 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced the expansion of its macrodissection portfolio with the launch of Breast Macrodissect AI . The suite now includes advanced algorithms for non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and breast
Indica Labs’ Frankfurt HALO® User Group Meeting 2026
17 March 2026 | Indica Labs is pleased to announce our Frankfurt HALO® User Group Meeting at The Hilton Frankfurt Airport on 17 March from 11:00 – 16:00.
Looking Back: Reviewing 2025 at Indica Labs
As we reach the end of 2025, the Indica Labs team extends our sincere thanks to the customers and collaborators who helped make this year one of remarkable innovation, growth, and scientific achievement.
Indica Labs Reports 260% Clinical Revenue Growth and Expansion into New Global Markets
Albuquerque, NM, December 17, 2025 – Indica Labs, the global leader in AI-powered digital pathology, announced today that clinical revenue growth rate for HALO AP® is up 260% since 2023 and recurring revenue for 2025 shows a 200% increase year-over-year, reinforcing its position as a market leader in digital pathology
Webinars and Events
Check out our upcoming and most popular webinars and events!
Masterclass: Unlock Cell Population Discovery Using HALO® High Dimensional Analysis
31 March 2026 | Learn how unbiased high-dimensional analysis can be seamlessly combined with AI-powered HALO workflows for multiplex images!
Indica Labs’ Frankfurt HALO® User Group Meeting 2026
17 March 2026 | Indica Labs is pleased to announce our Frankfurt HALO® User Group Meeting at The Hilton Frankfurt Airport on 17 March from 11:00 – 16:00.
HALO AP 2.5 Sneak Peek Webinar
16 April 2026 | Learn about the exciting new features in the 2.5 versions of HALO AP®!
Getting Started with HALO AI
5 March 2026 | Learn how to develop your own AI algorithms for segmentation, classification, and more using HALO AI
Towards Open Pathology: Facilitating Development of Novel AI-based Tools for Digital Pathology through Collaboration and Integration
16 October 2022 | In this 1-hour workshop, Eric Runde, Chief Operating Officer at Indica Labs, will introduce Indica’s platforms, our collaborative approach to incorporating artificial intelligence (AI) into life science and clinical workflows, and the open pathology tools available to developers and industry partners. Dr. Peter Caie, Principal Scientist
Adoption of the HALO® Platform at Caris Life Sciences’ High Volume Digital Pathology Laboratory
17 October 2021 | In this one-hour pre-conference workshop, Indica Labs is pleased to host Dr. Matthew Oberley, Executive Medical Director at Caris Life Sciences, who will present a case study on deploying HALO AP® case management software in their high-volume, fully digital, anatomic pathology lab. Dr. Oberley will discuss
Masterclass Webinar: Intro to the HALO AI Toolbox
29 June 2023 | Join us for this 1-hour webinar to see a breakdown of the networks that make up HALO AI and applications suitable for each one.
Choosing The Right Foundation: Selecting And Deploying An Image Management System For Diagnostic Digital Pathology
18 May 2023 | In this 60-minute webinar, we will discuss considerations when selecting a digital pathology image management system for clinical diagnostics. In the first half of the event, we pose questions and suggest approaches that your group may adopt when evaluating diagnostic digital pathology platforms. A comprehensive Vendor
Transforming Pathology at Nottingham University Hospitals: Implementing Digital Pathology using HALO AP®
2 March 2023 | Learn about transformational change in how pathology services are delivered at Nottingham University Hospitals
HALO Prostate AI – A Tool for Automated Detection and Gleason Grading of Prostate Cancer
05 October 2022 | Join us for this 1-hour webinar to learn how to implement the HALO Prostate AI tool for prostate cancer detection and grading
Towards Open Pathology: Facilitating Development of Novel AI-based Tools for Digital Pathology through Collaboration and Integration
16 October 2022 | In this 1-hour workshop, Eric Runde, Chief Operating Officer at Indica Labs, will introduce Indica’s platforms, our collaborative approach to incorporating artificial intelligence (AI) into life science and clinical workflows, and the open pathology tools available to developers and industry partners. Dr. Peter Caie, Principal Scientist
Adoption of the HALO® Platform at Caris Life Sciences’ High Volume Digital Pathology Laboratory
17 October 2021 | In this one-hour pre-conference workshop, Indica Labs is pleased to host Dr. Matthew Oberley, Executive Medical Director at Caris Life Sciences, who will present a case study on deploying HALO AP® case management software in their high-volume, fully digital, anatomic pathology lab. Dr. Oberley will discuss
Masterclass Webinar: Intro to the HALO AI Toolbox
29 June 2023 | Join us for this 1-hour webinar to see a breakdown of the networks that make up HALO AI and applications suitable for each one.
Choosing The Right Foundation: Selecting And Deploying An Image Management System For Diagnostic Digital Pathology
18 May 2023 | In this 60-minute webinar, we will discuss considerations when selecting a digital pathology image management system for clinical diagnostics. In the first half of the event, we pose questions and suggest approaches that your group may adopt when evaluating diagnostic digital pathology platforms. A comprehensive Vendor
Transforming Pathology at Nottingham University Hospitals: Implementing Digital Pathology using HALO AP®
2 March 2023 | Learn about transformational change in how pathology services are delivered at Nottingham University Hospitals
HALO Prostate AI – A Tool for Automated Detection and Gleason Grading of Prostate Cancer
05 October 2022 | Join us for this 1-hour webinar to learn how to implement the HALO Prostate AI tool for prostate cancer detection and grading
All Webinars
Explore all of our upcoming and past webinars by category.
Present with Indica Labs
Interested in presenting your work using HALO software at an Indica Labs webinar or user group meeting? Fill out the form below!
You can also drop us an email at marketing@indicalab.com and let us know!